Tengjun Biotechnology Corp
Tengjun Biotechnology Corp., through its subsidiaries, engages in producing, packaging, distributing, and marketing featured dandelion teas and water purifiers in the People's Republic of China. It offers black and green dandelion teas; and household water purifiers. The company was founded in 2010 and is headquartered in Jining, China.
Market Cap & Net Worth: Tengjun Biotechnology Corp (TJBH)
Tengjun Biotechnology Corp (OTCQB:TJBH) has a market capitalization of $201.42 Million ($201.42 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #16484 globally and #6343 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tengjun Biotechnology Corp's stock price $2.00 by its total outstanding shares 100711000 (100.71 Million).
Tengjun Biotechnology Corp Market Cap History: 2016 to 2025
Tengjun Biotechnology Corp's market capitalization history from 2016 to 2025. Data shows change from $392.77 Million to $201.42 Million (-7.35% CAGR).
Tengjun Biotechnology Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tengjun Biotechnology Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.68x
Tengjun Biotechnology Corp's market cap is 2.68 times its annual revenue
0.14x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
35.50x
Tengjun Biotechnology Corp's market cap is 35.50 times its annual earnings
5.50x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $5.54 Billion | $290.00 | -$53.87K | 19100362.07x | N/A |
| 2022 | $402.84 Million | $150.14 Million | $11.35 Million | 2.68x | 35.50x |
Competitor Companies of TJBH by Market Capitalization
Companies near Tengjun Biotechnology Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Tengjun Biotechnology Corp by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
Tengjun Biotechnology Corp Historical Marketcap From 2016 to 2025
Between 2016 and today, Tengjun Biotechnology Corp's market cap moved from $392.77 Million to $ 201.42 Million, with a yearly change of -7.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $201.42 Million | 0.00% |
| 2024 | $201.42 Million | -66.67% |
| 2023 | $604.27 Million | +50.00% |
| 2022 | $402.84 Million | +33.33% |
| 2021 | $302.13 Million | -94.55% |
| 2020 | $5.54 Billion | +340.00% |
| 2019 | $1.26 Billion | +400.00% |
| 2018 | $251.78 Million | -35.90% |
| 2016 | $392.77 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Tengjun Biotechnology Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $201.42 Million USD |
| MoneyControl | $201.42 Million USD |
| MarketWatch | $201.42 Million USD |
| marketcap.company | $201.42 Million USD |
| Reuters | $201.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.